phase readout
saveNCT05729711: TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
ACTIVE_NOT_RECRUITINGupdated just now
community read0 votes
Sponsor: AstraZeneca. Phase: . Conditions: Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)
view source ↗
comments(0)
5-min edit window · permanent after that